SUMMARY
The Cognigenics approach has four key strengths:
- 1. Our straightforward design employs a simple mechanism of action which requires only a single point of contact in cells.
2. CRISPR’s precise vector targeting to neurons produces positive results without any known side effects.
3. Our design approach is extensively supported by a large body of neuroscience experiments and validated in the laboratory.
4. The opportunity to achieve a solution using industry-standard CRISPR editing tools promises significantly lower R&D costs than custom drug development, and allows the company to leverage billions of dollars in ongoing global CRISPR R&D.
The Cognigenics approach has four key strengths:
- 1. Our straightforward design employs a simple mechanism of action which requires only a single point of contact in cells.
2. CRISPR’s precise vector targeting to neurons produces positive results without any known side effects.
3. Our design approach is extensively supported by a large body of neuroscience experiments and validated in the laboratory.
4. The opportunity to achieve a solution using industry-standard CRISPR editing tools promises significantly lower R&D costs than custom drug development, and allows the company to leverage billions of dollars in ongoing global CRISPR R&D.